Gene Query: IFFO1

Dataset Description Geneva Score
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 33.56
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 29.9
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 23.94
Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain 23.35
Tumor exosome integrins determine organotropic metastasis 22.67
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 21.83
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 21.52
RNA sequencing of BT142 and TS603 cell lines 20.91
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 20.91
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 17.73
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 17.64
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes 16.4
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 16.21
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 16.1
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 15.36
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 14.97
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 14.43
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 13.92
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 13.82
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 13.03
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 12.71
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 12.71
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 12.71
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 12.71
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 12.68
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 12.54
Effect of mitochondria deficiency on senescence-associated gene expression 11.73
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 11.08
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 10.79
ZIKV infection of monocytes activates inflammasome pathways 10.71
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 10.71
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 10.71
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 10.65
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 10.55
10.52
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 10.4
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 10.27
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 10.25
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 10.25
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 10.1
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 9.89
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 9.8
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 9.8
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 9.36
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 9.27
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 9.14
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 9.12
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 9.12
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 9.07
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 9.01
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 8.99
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 8.97
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 8.93
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 8.93
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 8.92
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 8.89
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 8.85
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 8.83
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 8.76
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 8.64
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 8.62
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 8.62
RNA sequencing of human fibroblasts after SUPT4H1 siRNA treatment 8.59
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 8.55
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 8.52
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 8.36
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 8.27
Random mono-allelic expression in MECP2-mutated cells 8.23
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 8.16
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 8.16
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 8.15
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 8.11
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 8.05
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 8.03
Cleavage Factor Im as a key regulator of 3’ UTR length 7.99
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 7.99
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 7.83
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 7.74
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 7.7
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 7.68
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 7.56
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 7.54
Pharmacologic inhibition of STAT5 in AML 7.54
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 7.51
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 7.51
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 7.5
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 7.46
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 7.4
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 7.36
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 7.35
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 7.28
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 7.17
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 7.15
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 6.93
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 6.87
quanTIseq: quantifying immune contexture of human tumors 6.85
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 6.76
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 6.63
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 6.6
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 6.6
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 6.55
Characterization of human ILC2 subsets 6.53
RNA-seq of tumor cells following angiopellosis extravasation 6.52
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 6.51
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 6.41
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 6.39
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 6.28
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 6.21
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 6.21
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 6.18
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 6.18
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 5.83
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 5.81
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 5.8
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 5.77
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 5.76
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 5.76
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 5.74
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 5.72
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 5.71
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 5.64
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 5.61
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 5.61
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 5.42
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 5.31
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 5.28
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 5.27
In vivo genome editing restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers 5.2
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 5.1
Intron retention induced by microsatellite expansions as a disease biomarker. 5.03
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 5.01
Primary Human B-cell Temporal Response to CD40L Stimulation 4.99
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 4.94
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 4.86
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 4.86
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 4.86
hTERT promotes cell adhesion and migration independent of telomerase activity 4.86
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 4.85
Gene expression in GBM with Cav3.2 inhibition 4.84
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 4.83
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 4.82
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 4.82
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 4.82
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 4.81
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 4.79
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 4.67
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 4.65
Targeting MTHFD2 in Acute Myeloid Leukemia 4.65
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 4.61
mRNA expression profile of Lymphocytes by high-throuput sequencing 4.59
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 4.55
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 4.55
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 4.54
Macrophage Ad5f35 M2 Challenge 4.5
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 4.48
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 4.47
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 4.46
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 4.4
A transcriptome-wide divergence in protein translation scales with LIN28B expression 4.33
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 4.29
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  4.26
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 4.25
Gene expression profiling of human and murine in vitro muscle differentiation 4.24
RNA-seq analysis of AML cells in response to ASLAN003 4.22
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 4.21
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 4.2
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 4.2
RNA-seq analysis upon ARID1B overexpression 4.08
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 4.05
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 4.05
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 4.04
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 4.04
Tpl-2 small molecule project 4.04
Tpl-2 and MEK small molecule inhibitors 4.04
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 4.03
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 4.02
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 3.98
Transcriptome analysis of peripheral blood monocytes 3.95
MARS Seq data from human cortical organoids 3.94
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 3.94
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 3.94
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 3.94
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 3.91
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 3.89
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 3.89
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 3.89
Microglia innatly develop within cerebral organoids 3.87
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 3.86
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 3.86
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 3.85
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 3.85
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 3.85
Transcriptome analysis of SKI knock-out in HL60 cells 3.85
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 3.82
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 3.8
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 3.8
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 3.8
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 3.8
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 3.77
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 3.77
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 3.76
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 3.76
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 3.76
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 3.76
Stem and effector CD8 T-cells from human cancers 3.75
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 3.71
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 3.69
Transcriptome wide analysis of classically and alternatively activated macrophages 3.69
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 3.68
UV_24h_GRO-Seq 3.68
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 3.68
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 3.64
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 3.62
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 3.61
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 3.58
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 3.58
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 3.58
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 3.58
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 3.58
RNA polymerase in pre-B-ALL cell lines 3.58
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 3.55
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.54
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 3.53
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 3.52
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 3.52
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 3.52
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 3.5
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 3.49
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 3.49
Gene expression changes in human melanoma cell lines compared to primary melanocytes 3.47
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 3.47
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 3.44
Transcriptome Profiling of Human Primary Monocytes 3.44
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 3.43
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 3.42
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 3.36
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 3.36
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 3.35
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 3.32
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 3.32
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 3.31
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 3.27
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 3.26
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 3.26
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 3.23
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 3.23
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 3.23
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 3.23
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 3.21
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 3.2
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 3.17
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 3.17
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 3.15
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 3.15
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 3.05
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 3.04
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 3.03
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 3.03
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 3.01
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 3.0
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 3.0
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 3.0
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 2.99
RNAseq Analysis in glioblastoma cells treated with Mepazine 2.98
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 2.96
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 2.96
Macrophage Ad5f35 PhenoMap 2.95
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 2.94
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 2.93
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 2.92
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 2.89
Transciptomic profiling of human fetal lung samples 2.89
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 2.88
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 2.88
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 2.87
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 2.85
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 2.85
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 2.85
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 2.84
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 2.81
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 2.81
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 2.79
Deletions in the ATAD3 gene cluster cause cerebellar developmental defects with mitochondrial DNA abnormalities owing to local cholesterol insufficiency 2.77
Intrahepatic MAIT cell gene expression revealed by RNA-seq 2.76
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 2.7
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 2.68
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 2.68
Transcription control by the ENL YEATS domain in acute leukemia 2.67
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 2.67
Gene expression analysis upon mtDNA depletion 2.66
Gene expression analysis upon mtDNA depletion [RNA-seq] 2.66
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 2.65
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 2.65
A map of gene expression in neutrophil-like cell lines 2.63
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 2.62
Trascriptome of thyroid cancer-induced macrophages 2.6
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 2.6
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 2.6
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 2.6
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 2.59
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 2.58
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 2.58
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 2.57
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 2.55
Transcriptional responses of melanoma cells to BRAF inhibition 2.55
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 2.54
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 2.54
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 2.53
CD74 role in transcription regulation [RNA-seq] 2.52
CD74 role in transcription regulation 2.52
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 2.52
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 2.48
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 2.46
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 2.46
Genome-wide Analysis of Chromatin Interactions in Human Cells 2.44
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 2.41
Dysregulated immune system networks in war veterans with PTSD 2.38
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 2.37
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 2.36
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 2.36
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 2.35
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 2.35
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 2.35
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 2.34
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 2.29
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 2.24
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 2.24
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 2.2
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 2.17
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 2.1
Bone marrow derived human B cells [normal proB] 2.09
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 2.06
Human Airway Smooth Muscle Transcriptome Changes in Response to Asthma Medications 2.06
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 2.05
Finding missing proteins from epigenetically manipulated human cells 2.03
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 2.02
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 2.01
Transcriptome Analysis and Functional Identification of Adipose-Derived Mesenchymal Stem Cells in Secondary Lymphedema 1.98
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 1.98
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 1.93
Regulating Interleukin-2 activity with engineered receptor signaling clamps 1.93
TFAP2C signalling in human fibroblasts 1.93
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 1.92
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 1.92
Genome-wide mapping of TEL-AML1 targets in acute leukemia 1.91
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 1.9
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 1.9
Gene expression profile of CRC-derived HILEC 1.87
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 1.83
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 1.83
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells II 1.82
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 1.82
mRNAseq of Huntington's disease and control patient iPSC-derived neural cells 1.81
Transcriptomic and Epigenomic analysis of Huntington's disease and control patient iPSC-derived neural cells 1.81
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 1.78
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 1.78
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 1.73
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 1.72
Effects of rFVIIIFc on human macrophages 1.71
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 1.7
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 1.7
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 1.68
Induced DNA demethylation, genome instability and transcription 1.68
X-Ray induced DNA-Hydroxymethylation changes 1.65
ENCODE Cold Spring Harbor Labs Long RNA-seq 1.64
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 1.64
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 1.64
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 1.61
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 1.57
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 1.57
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 1.56
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 1.55
Transcriptome of activated human and mouse MAIT cells 1.53
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 1.49
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 1.48
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 1.47
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 1.45
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 1.45
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 1.45
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 1.42
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 1.41
Redifferentiation of expanded human islet β cells by inhibition of ARX 1.39
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 1.38
Identification of renal resident macrophages across species [C1] 1.37
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 1.37
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 1.34
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 1.33
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 1.33
Transcriptome of Stabilin-1 siRNA transfected human monocytes 1.33
RNA sequencing of T-ALL (COG study) 1.32
Analyses of T-ALL (COG study) 1.32
Aortic Valve Tissue: Stenosis vs. Sclerosis 1.31
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders 1.31
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 1.25
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 1.25
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 1.24
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 1.22
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 1.21
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 1.21
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 1.21
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 1.2
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 1.2
RNA editing in nascent RNA affects pre-mRNA splicing 1.13
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 1.1
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 1.09
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 1.09
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 1.08
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 1.08
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 1.03
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 1.01
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.99
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 0.99
RNA-seq in endometrial stromal tumors 0.98
Myc activation coordinates gene transcription and protein translation responses 0.92
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 0.87
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 0.85
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 0.85
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 0.85
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 0.81
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 0.81
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 0.81
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.81
miRNAs affected by antagomiR-17 treatment 0.8
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 0.8
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 0.78
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.74
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 0.74
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 0.71
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.71
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.7
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 0.7
Identification of renal resident macrophages across species 0.69
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 0.69
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 0.67
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 0.65
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 0.64
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 0.64
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 0.61
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 0.6
MHC Transcriptomic landscape at haplotype-specific resolution 0.6
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.59
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.57
BACH2 in human plasma cell fate decision 0.57
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.56
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.55
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 0.55
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.53
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.53
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 0.53
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.52
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 0.52
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 0.52
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 0.5
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 0.5
Function and hormonal regulation of GATA3 in human first trimester placentation 0.5
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.49
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 0.49
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 0.48
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 0.47
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 0.47
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 0.47
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.47
Transcriptomes in healthy and CHB fetal hearts 0.47
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 0.4
Widespread regulated alternative splicing of single codons accelerates proteome evolution 0.4
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 0.34
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 0.34
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 0.34
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 0.34
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 0.32
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 0.31
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 0.31
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.3
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 0.29
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 0.27
SF3B1 Degron knockdown RNA-seq 0.26
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.26
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.26
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 0.25
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.21
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.21
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 0.2
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 0.2
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 0.2
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 0.2
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.18
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.18
Leucegene: AML sequencing (part 6) 0.18
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 0.18
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.08
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 0.08
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 0.08
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 0.06
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription [RNA-Seq] 0.04
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription 0.04
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 0.04
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 0.04
BMS-470539 on human synovial fibroblasts 0.03
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 0.02
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation